Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state
| Autor: | Veena, Kochat, Ayush T, Raman, Sharon M, Landers, Ming, Tang, Jonathan, Schulz, Christopher, Terranova, Jace P, Landry, Angela D, Bhalla, Hannah C, Beird, Chia-Chin, Wu, Yingda, Jiang, Xizeng, Mao, Rossana, Lazcano, Swati, Gite, Davis R, Ingram, Min, Yi, Jianhua, Zhang, Emily Z, Keung, Christopher P, Scally, Christina L, Roland, Kelly K, Hunt, Barry W, Feig, P Andrew, Futreal, Patrick, Hwu, Wei-Lien, Wang, Alexander J, Lazar, John M, Slopis, Heather, Wilson-Robles, Dominique J, Wiener, Ian E, McCutcheon, Brandan, Wustefeld-Janssens, Kunal, Rai, Keila E, Torres |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Homeodomain Proteins
Polycomb Repressive Complex 2 Cell Cycle Proteins Cell Differentiation Mice Transgenic Xenograft Model Antitumor Assays Nerve Sheath Neoplasms Epigenesis Genetic Mice Dogs Enhancer Elements Genetic Species Specificity Neural Crest Peripheral Nervous System Neoplasms Cell Line Tumor Mutation Biomarkers Tumor Animals Humans Zebrafish Transcription Factors |
| Zdroj: | Acta neuropathologica. 142(3) |
| ISSN: | 1432-0533 |
| Popis: | Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that frequently harbor genetic alterations in polycomb repressor complex 2 (PRC2) components-SUZ12 and EED. Here, we show that PRC2 loss confers a dedifferentiated early neural-crest phenotype which is exclusive to PRC2-mutant MPNSTs and not a feature of neurofibromas. Neural crest phenotype in PRC2 mutant MPNSTs was validated via cross-species comparative analysis using spontaneous and transgenic MPNST models. Systematic chromatin state profiling of the MPNST cells showed extensive epigenomic reprogramming or chromatin states associated with PRC2 loss and identified gains of active enhancer states/super-enhancers on early neural crest regulators in PRC2-mutant conditions around genomic loci that harbored repressed/poised states in PRC2-WT MPNST cells. Consistently, inverse correlation between H3K27me3 loss and H3K27Ac gain was noted in MPNSTs. Epigenetic editing experiments established functional roles for enhancer gains on DLX5-a key regulator of neural crest phenotype. Consistently, blockade of enhancer activity by bromodomain inhibitors specifically suppressed this neural crest phenotype and tumor burden in PRC2-mutant PDXs. Together, these findings reveal accumulation of dedifferentiated neural crest like state in PRC2-mutant MPNSTs that can be targeted by enhancer blockade. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink